Production (Stage)
Protagenic Therapeutics, Inc.
PTIX
$3.62
$0.1353.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -63.98% | -54.67% | -79.98% | -84.70% | -68.32% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 25.45% | -69.17% | 252.45% | -49.21% | 214.29% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -62.39% | -55.17% | -73.54% | -80.21% | -67.80% |
|
|
|||||
| Total Current Assets | -62.39% | -55.17% | -73.54% | -80.21% | -67.80% |
| Net Property, Plant & Equipment | -45.40% | -40.79% | 52.86% | 6,037.50% | 6,417.65% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -61.66% | -54.76% | -72.24% | -78.80% | -66.36% |
|
|
|||||
| Total Accounts Payable | 51.56% | -9.49% | -55.40% | -40.90% | -37.68% |
| Total Accrued Expenses | 170.45% | 55.09% | 10.36% | -39.02% | -52.39% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 141.43% | 43.87% | -38.34% | -55.19% | -64.37% |
|
|
|||||
| Total Current Liabilities | 141.43% | 43.87% | -38.34% | -55.19% | -64.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 141.43% | 43.87% | -38.34% | -55.19% | -64.37% |
|
|
|||||
| Common Stock & APIC | 8.82% | 8.35% | 5.10% | 3.93% | 3.53% |
| Retained Earnings | -16.13% | -17.95% | -19.41% | -23.11% | -22.67% |
| Treasury Stock & Other | -49.65% | -14.45% | 78.92% | 77.80% | 86.20% |
| Total Common Equity | -104.14% | -72.38% | -82.69% | -85.36% | -66.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -104.14% | -72.38% | -82.69% | -85.36% | -66.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -104.14% | -72.38% | -82.69% | -85.36% | -66.75% |
|
|
|||||